WO2023243164A1 - カプセル状服薬デバイスおよびカプセル状服薬デバイスの充電システム - Google Patents
カプセル状服薬デバイスおよびカプセル状服薬デバイスの充電システム Download PDFInfo
- Publication number
- WO2023243164A1 WO2023243164A1 PCT/JP2023/009768 JP2023009768W WO2023243164A1 WO 2023243164 A1 WO2023243164 A1 WO 2023243164A1 JP 2023009768 W JP2023009768 W JP 2023009768W WO 2023243164 A1 WO2023243164 A1 WO 2023243164A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- capsule
- medication device
- shaped
- center
- shaped medication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—ELECTRIC POWER NETWORKS; CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J50/00—Circuit arrangements or systems for wireless supply or distribution of electric power
- H02J50/10—Circuit arrangements or systems for wireless supply or distribution of electric power using inductive coupling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/073—Intestinal transmitters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6861—Capsules, e.g. for swallowing or implanting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—ELECTRIC POWER NETWORKS; CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J50/00—Circuit arrangements or systems for wireless supply or distribution of electric power
- H02J50/70—Circuit arrangements or systems for wireless supply or distribution of electric power involving the reduction of electric, magnetic or electromagnetic leakage fields
-
- H—ELECTRICITY
- H02—GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
- H02J—ELECTRIC POWER NETWORKS; CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY
- H02J7/00—Circuit arrangements for charging or discharging batteries or for supplying loads from batteries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4833—Assessment of subject's compliance to treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0272—Electro-active or magneto-active materials
- A61M2205/0294—Piezoelectric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8237—Charging means
- A61M2205/8243—Charging means by induction
Definitions
- the present invention relates to a capsule-shaped medication device and a charging system for the capsule-shaped medication device.
- Patent Document 1 discloses that when a medication device containing a drug is taken, a current flows through a conductive liquid such as gastric fluid to a drive circuit included in the medication device, transmitting a signal, and transmitting a signal to an external receiving device. A system is described that detects that a medication device has been taken by receiving a signal.
- gastric acid batteries which pass current through a conductive liquid such as gastric fluid to the drive circuit, are suitable for systems that only require power for short periods of time, but they are suitable for systems that only require power for short periods of time, such as keeping medication devices in the body for long periods of time. It is not suitable for a system that acquires biological information by retaining it and transmits the acquired biological information outside the body. Therefore, a configuration may be considered in which a small secondary battery that can supply power at the required timing is provided in the medication device.
- the present invention solves the above-mentioned problems, and aims to provide a capsule-shaped medication device and a charging system for the capsule-shaped medication device that can efficiently charge a secondary battery provided therein. shall be.
- the capsule-like medication device of the present invention includes: A capsule-shaped casing, a board disposed inside the casing; a power receiving coil provided on the substrate; a secondary battery that can be charged with the power received by the power receiving coil; Equipped with The center of gravity of the capsule-shaped medication device is at a position different from the center of a cut plane when the capsule-shaped medication device is cut along a plane passing through the position of the center of gravity and orthogonal to the longitudinal direction of the capsule-shaped medication device. and is located at a position overlapping the substrate when viewed in a direction perpendicular to the substrate.
- the charging system for the capsule-shaped medication device of the present invention includes: A storage sheet having a plurality of storage sections and a metal cover that covers openings of the plurality of storage sections;
- the capsule-shaped medication device of the present invention When the capsule-shaped medication device of the present invention is placed on a charger having a power transmitting coil, the power receiving coil and the power transmitting coil are not in a perpendicular positional relationship, so that efficient wireless power supply can be performed. The next battery can be charged efficiently. Additionally, when placed on a charger that has a power transmitting coil, the relative positional relationship between the power transmitting coil and the power receiving coil is uniquely determined, making it possible to suppress charging variations when performing wireless charging. can.
- charging can be performed with high charging efficiency simply by placing the accommodation sheet in which the capsule-shaped medication device is housed in the accommodation section on a charger having a power transmission coil. Can be done.
- FIG. 2 is a plan view schematically showing the shape of a power receiving coil provided on a substrate.
- FIG. 3 is a diagram schematically showing the external shapes of a first divided housing and a second divided housing that constitute the housing.
- FIG. 2 is a side cross-sectional view schematically showing the configuration of a charging system for a capsule-shaped medication device.
- FIG. 3 is a side cross-sectional view schematically showing a posture when charging a capsule-shaped medication device that is located at a position different from the center of the device but does not overlap with the substrate when viewed in a direction perpendicular to the substrate.
- FIG. 4 is a diagram for explaining the angle ⁇ between the reference line extending in the direction orthogonal to the substrate.
- 3 is a diagram showing the relationship between the angle ⁇ between the reference line extending in a direction perpendicular to the substrate and the output voltage of a rectifier bridge circuit installed at a subsequent stage of the power receiving coil.
- the capsule-shaped medication device 10 in one embodiment is ingested together with a medicine, and can, for example, transmit biological information to the outside of the body.
- the drug taken with the capsule medication device 10 is any drug.
- FIG. 1(a) is a side view schematically showing a capsule-shaped medication device 10 in one embodiment.
- FIG. 1(b) is a cross-sectional view schematically showing the configuration of the capsule-shaped medication device 10 shown in FIG. 1(a) taken along line 1B-1B.
- FIG. 1(c) is a cross-sectional view schematically showing the configuration of the capsule-shaped medication device 10 shown in FIG. 1(a) taken along line 1C-1C.
- the X-axis direction is the longitudinal direction of the capsule-shaped medication device 10
- the Y-axis direction is the lateral direction.
- the Z axis is an axis perpendicular to the X axis and the Y axis, respectively.
- a capsule-shaped medication device 10 in one embodiment includes a capsule-shaped housing 1, a substrate 2, a power receiving coil 3, and a secondary battery 4.
- the housing 1 is made of, for example, a biocompatible resin or a general-purpose resin whose surface is coated with a biocompatible material.
- a biocompatible resin for example, epoxy resin can be used as the biocompatible resin.
- epoxy resin can be used as the biocompatible resin.
- the material used for the housing 1 it is preferable to use a material that can be excreted from the body without being dissolved by gastric acid or the like after the capsule-shaped medication device 10 is taken into the body.
- the board 2 is placed inside the housing 1.
- the number of substrates 2 placed inside the housing 1 may be one or more.
- the board 2 may include a board on which the power receiving coil 3 is provided, a board on which the secondary battery 4 is provided, and a board on which a control IC is provided.
- the power receiving coil 3 is provided on the substrate 2 to pair with the power transmitting coil to perform wireless power supply.
- the power receiving coil 3 is made of copper, for example.
- Wireless power supply can be performed using electromagnetic induction technology or magnetic resonance technology.
- magnetic field resonance is a type of electromagnetic induction because current flows through the power receiving coil 3 in response to changes in the magnetic field created by the power transmitting coil.
- FIG. 2 is a plan view schematically showing the shape of the power receiving coil 3 provided on the substrate 2. As shown in FIG. Although not shown in FIG. 2, the power receiving coil 3 is connected to the secondary battery 4.
- the secondary battery 4 can be charged with power received by the power receiving coil 3.
- the secondary battery 4 may be any type of battery as long as it can be charged and discharged, such as an all-solid battery having a solid electrolyte.
- the secondary battery 4 is provided, for example, on the substrate 2 on which the power receiving coil 3 is provided. However, the position where the secondary battery 4 is provided is not limited to the top of the substrate 2 where the power receiving coil 3 is provided.
- the capsule-shaped medication device 10 may further include a biological information acquisition section 5 and a signal transmission section 6. Electric power is supplied to the biological information acquisition section 5 and the signal transmission section 6 from the secondary battery 4 .
- FIG. 1 shows a configuration in which a biological information acquisition section 5 and a signal transmission section 6 are provided on a substrate 2 on which a power reception coil 3 is provided, the positions where the biological information acquisition section 5 and signal transmission section 6 are provided are shown in FIG. is not limited to the top of the substrate 2.
- the biological information acquisition unit 5 acquires biological information such as the position in the body of the capsule-shaped medication device 10 taken together with the medicine, and the temperature in the body.
- the biological information acquisition unit 5 has a timer capable of measuring time, measures the time that has passed since the capsule-shaped medication device 10 was taken into the body, and according to the measured time, The position of the medication device 10 in the body is estimated.
- the biological information acquisition unit 5 includes a temperature sensor and detects the temperature inside the body.
- the biometric information includes all kinds of information regarding a living body, and the biometric information acquisition unit 5 can be configured to acquire any biometric information.
- the signal transmitting unit 6 transmits the biological information acquired by the biological information acquiring unit 5. That is, after the capsule-shaped medication device 10 is taken into the body, the signal transmitting unit 6 transmits the biological information acquired by the biological information acquiring unit 5 to outside the body.
- the signal transmitter 6 is, for example, a piezoelectric element, and transmits biological information as an ultrasonic signal.
- the material of the piezoelectric element PZT (lead zirconate titanate), BT (barium titanate), KNN (potassium sodium niobate), etc. can be used.
- the capsule-like medication device 10 includes an IC for controlling the piezoelectric element.
- the signal transmitter 6 is a piezoelectric element, biological information can be reliably transmitted outside the body as an ultrasonic signal.
- the signal transmitted from the signal transmitter 6 is received by a signal receiver provided outside the body.
- the signal transmitter 6 is a piezoelectric element and transmits an ultrasonic signal
- the vibration mode is a lateral displacement type (d31 mode)
- the longer the length of the piezoelectric element the stronger the ultrasonic signal. be able to.
- the capsule-shaped medication device 10 in this embodiment has a capsule-shaped shape, it is possible to house a long piezoelectric element therein, and it is possible to transmit a strong ultrasonic signal.
- the signal transmitter 6 is not limited to a piezoelectric element.
- the signal transmitter 6 may be configured to transmit biological information by wireless communication.
- the biological information acquisition section 5 and the signal transmission section 6 are supplied with power from the secondary battery 4.
- the biological information acquisition section 5 can acquire biological information at any position within the body.
- the signal transmitter 6 can transmit biological information from any position within the body.
- FIG. 1(c) shows a cut surface 13 when the capsule-shaped medication device 10 is cut along a plane that passes through the position of the center of gravity 11 of the capsule-shaped medication device 10 and is orthogonal to the longitudinal direction of the capsule-shaped medication device 10. .
- the cut surface 13 is circular, as shown in FIG. 1(c). Note that the center of gravity 11 of the capsule-shaped medication device 10 can be determined by a known method.
- the center of gravity 11 of the capsule-shaped medication device 10 passes through the capsule-shaped medication device 10 through the position where the center of gravity 11 is, as shown in FIG. A position different from the center 12 of the cut surface 13 when cut along a plane perpendicular to the longitudinal direction of the substrate 10, and when viewed in a direction perpendicular to the substrate 2, as shown in FIG. 1(b). It is located at a position overlapping with the substrate 2.
- the housing 1 is configured by combining a first divided housing 1a and a second divided housing 1b.
- FIG. 3 shows the first divided housing 1a and the second divided housing 1b before being combined.
- the substrate 2 is indicated by a dotted line in order to show an example of the arrangement position of the substrate 2, as will be described later.
- the first divided casing 1a and the second divided casing 1b have shapes that are divided by cutting the casing 1 along a plane that passes through the center of the lateral direction of the casing 1 and is parallel to the longitudinal direction.
- the first divided housing 1a and the second divided housing 1b can be manufactured by, for example, injection molding or a manufacturing method using a 3D printer.
- the first divided housing 1a and the second divided housing 1b can be combined using an adhesive or the like.
- the weight of the first divided housing 1a and the weight of the second divided housing 1b are adjusted. be configured differently. For example, by making the weight of the second divided housing 1b heavier than the weight of the first divided housing 1a, the center of gravity 11 of the capsule-shaped medication device 10 is positioned on the side of the second divided housing 1b. Can be adjusted.
- the housing 1 is configured by combining the first divided housing 1a and the second divided housing 1b, and the weight of the first divided housing 1a and the weight of the second divided housing 1b are By making the weights different, it is possible to easily set the center of gravity 11 of the capsule-like medication device 10 to a desired position.
- a weight is attached to either the first divided housing 1a or the second divided housing 1b. may be provided.
- the weight has at least one angle when viewed in the direction perpendicular to the substrate 2. It is preferable to provide a portion where the portion overlaps the substrate 2, and it is more preferable to provide a portion where the entire portion overlaps the substrate 2.
- the board 2 may be provided inside the second divided housing 1b, or may be provided inside the first divided housing 1a.
- the board 2 may be placed inside the second divided housing 1b or the first divided housing 1a by fitting, or by using screws, adhesive, double-sided tape, etc. Good too.
- a weight is provided on the substrate 2, and the weight is placed on either of the first divided housing 1a and the second divided housing 1b.
- the board 2 provided with a weight may be placed inside one of the divided housings.
- FIG. 4 is a side sectional view schematically showing the configuration of the charging system 100 for a capsule-shaped medication device.
- a charging system 100 for a capsule-shaped medication device includes a capsule-shaped medication device 10, an accommodation sheet 20, and a charger 30.
- the storage sheet 20 has a plurality of storage sections 21 and a metal cover 22 that covers the openings of the plurality of storage sections 21.
- the accommodation sheet 20 is, for example, a PTP sheet (Press Through Pack Sheet).
- the portion of the accommodation sheet 20 that constitutes the accommodation section 21 is made of, for example, resin, and the metal cover 22 is made of, for example, aluminum.
- the capsule-shaped medication device 10 is accommodated in the accommodating portion 21 of the accommodating sheet 20.
- FIG. 4 shows a state in which the capsule-shaped medication device 10 is accommodated through the opening of the accommodating portion 21 and the opening is covered with a metal cover 22.
- each accommodating portion 21 accommodates one capsule-shaped medication device 10.
- a plurality of capsule-shaped medication devices 10 may be accommodated in one accommodating portion 21 .
- a medicine to be taken at one time and the capsule-shaped medication device 10 may be stored in one housing part 21.
- one accommodating portion 21 can accommodate the plurality of drugs and one capsule-like medication device 10 .
- the secondary battery 4 of the capsule-shaped medication device 10 accommodated in the accommodation section 21 of the accommodation sheet 20 can be charged by the charger 30.
- Charger 30 includes a power transmission coil 31 for wireless power supply.
- a plurality of power transmission coils 31 may be provided in the charger 30, or only one power transmission coil 31 may be provided in the charger 30.
- the power transmission coil 31 is provided at a placement surface 30a on which the accommodation sheet 20 is placed in the charger 30, or at a position close to the placement surface 30a.
- the power transmitting coil 31 is provided at the mounting surface 30a of the charger 30 or at a position close to the mounting surface 30a, so that the distance between the power transmitting coil 31 and the power receiving coil 3 of the capsule-shaped medication device 10 becomes short, so that the power consumption is high. Wireless charging can be performed with charging efficiency.
- the portion where the accommodating sheet 20 comes into contact with the charger 30 when charging the secondary battery 4 of the capsule-shaped medication device 10 is on the opposite side of the metal cover 22. That is, as shown in FIG. 4, the storage sheet 20 is placed on which the charger 30 is placed so that the portion of the storage sheet 20 opposite to the metal cover 22 faces the placement surface 30a of the charger 30. Place it on the surface 30a.
- the storage sheet 20 is placed on which the charger 30 is placed so that the portion of the storage sheet 20 opposite to the metal cover 22 faces the placement surface 30a of the charger 30. Place it on the surface 30a.
- charging of the capsule-shaped medication device 10 accommodated in the accommodating portion 21 of the accommodation sheet 20 is carried out by the patient himself/herself taking the drug or by the capsule-shaped medication device 10 along with the medication. This can be done at a pharmacy where the drug is given to the patient.
- the center of gravity 11 is the cut plane 13 when the capsule-shaped medication device 10 is cut along a plane that passes through the position of the center of gravity 11 and is perpendicular to the longitudinal direction. It is at a position different from the center 12 of , and at a position overlapping with the substrate 2 when viewed in a direction perpendicular to the substrate 2 .
- FIG. 5(a) is a side sectional view schematically showing the posture when charging the capsule-like medication device 10 in this embodiment, and FIG. 5(b) shows that the center of gravity 11X is aligned with the center 12X of the above-mentioned cut plane 13X.
- FIG. 5(c) a side cross-sectional view schematically showing the posture when charging the matching capsule-shaped medication device 10X, shows that the center of gravity 11Y is located at a different position from the center 12Y of the cut surface 13Y described above, but the substrate 2Y FIG.
- FIG. 3 is a side cross-sectional view schematically showing the posture when charging the capsule-shaped medication device 10Y, which is located at a position that does not overlap with the substrate 2Y when viewed in a direction orthogonal to the substrate 2Y.
- the charger 30 is omitted in FIGS. 5(a) to (c)
- the capsule-shaped medication devices 10, 10X, and 10Y are placed on the mounting surface 30a of the charger 30, as in FIG. Indicates the condition. That is, in FIGS. 5(a) to 5(c), the charger 30 is located vertically below the capsule-shaped medication devices 10, 10X, and 10Y.
- the capsule-shaped medication device 10X shown in FIG. 5(b) and the capsule-shaped medication device 10Y shown in FIG. 5(c) are not capsule-shaped medication devices of the present invention.
- the components corresponding to the capsule-shaped medication device 10 will be described with the same reference numerals plus an X.
- the components corresponding to the capsule-shaped medication device 10 will be explained by adding Y to the same reference numerals.
- the capsule-shaped medication device 10X when the center of gravity 11X of the capsule-shaped medication device 10X coincides with the center 12X of the above-mentioned cut surface 13X, the capsule-shaped medication device 10X is placed on the mounting surface 30a of the charger 30. At times, the capsule-like medication device 10X is rotatable about a centerline that passes through the center of gravity 11X and is parallel to the longitudinal direction. Therefore, the capsule-like medication device 10X is in a state where it is easy to rotate and move within the housing section 21 of the housing sheet 20, and the relative relationship between the power transmitting coil 31 of the charger 30 and the power receiving coil 3X of the capsule-like medication device 10X is The positional relationship is not uniquely determined. Therefore, as shown in FIG.
- the substrate 2X of the capsule-shaped medication device 10X may be in a positional relationship perpendicular to the mounting surface 30a of the charger 30.
- the power receiving coil 3X provided on the board 2X and the power transmitting coil 31 of the charger 30 are in a positional relationship that is orthogonal to each other, the power feeding efficiency of wireless power feeding becomes low, and therefore the charging of the secondary battery 4X Efficiency will be lower.
- the capsule-shaped medication devices 10X are in a state where they are likely to rotate and move within the storage section 21 of the storage sheet 20, the secondary batteries 4X of the plurality of capsule-shaped medication devices 10X are charged depending on the difference in posture. When this happens, charging variations occur.
- the center of gravity 11Y of the capsule-shaped medication device 10Y is located at a different position from the center 12Y of the cut surface 13Y, when viewed in the direction perpendicular to the substrate 2Y, , the angle between the mounting surface 30a of the charger 30 and the board 2Y becomes large, so that part of the magnetic flux generated by the current flowing through the power transmitting coil 31 passes through the power receiving coil 3Y. The amount of things decreases. Therefore, the power feeding efficiency of wireless power feeding becomes low, and the charging efficiency of the secondary battery 4X becomes low.
- the capsule-shaped medication of this embodiment has a center of gravity 11 at a position different from the center 12 of the above-mentioned cut surface 13 and overlaps with the substrate 2 when viewed in a direction perpendicular to the substrate 2.
- the relative positional relationship between power transmitting coil 31 and power receiving coil 3 is uniquely determined. That is, since the center of gravity 11 is located vertically below the center 12 of the cut surface 13 described above, the angle formed between the mounting surface 30a of the charger 30 and the substrate 2 does not change. Therefore, it is possible to suppress charging variations when wirelessly charging the secondary batteries 4 of the plurality of capsule-shaped medication devices 10 respectively accommodated in the plurality of accommodating portions 21 of the accommodating sheet 20.
- the center of gravity 11 of the capsule-shaped medication device 10 is located on a reference line 14 that passes through the center 12 of the above-mentioned cut surface 13 and extends in a direction perpendicular to the substrate 2, as shown in FIG. 5(a). is preferred.
- the capsule-shaped medication device 10 is placed on the charger 30.
- the mounting surface 30a of the charger 30 and the substrate 2 of the capsule-shaped medication device 10 are parallel to each other. To position. Therefore, since the power receiving coil 3 and the power transmitting coil 31 are positioned in parallel to each other, wireless power can be supplied with the highest power supply efficiency, and the secondary battery 4 can be charged most efficiently.
- the output voltage of the rectifier bridge circuit when the angle ⁇ is 75° or less is 60% or more of the output voltage of the rectifier bridge circuit when the angle ⁇ is 0°. Become. Therefore, between a line 15 connecting the center of gravity 11 of the capsule-shaped medication device 10 and the center 12 of the cut surface 13 described above and a reference line 14 passing through the center 12 of the cut surface 13 and extending in a direction perpendicular to the substrate 2.
- the angle ⁇ is preferably 75° or less.
- the output voltage of the rectifier bridge circuit is 80% or more of the output voltage of the rectifier bridge circuit when the angle ⁇ is 0°. be. Therefore, between a line 15 connecting the center of gravity 11 of the capsule-shaped medication device 10 and the center 12 of the cut surface 13 described above and a reference line 14 passing through the center 12 of the cut surface 13 and extending in a direction perpendicular to the substrate 2. It is more preferable that the angle ⁇ is 45° or less.
- the angle ⁇ is preferably 75° or less, more preferably 45° or less.
- the capsule-shaped medication device and the charging system for the capsule-shaped medication device in the present application are as follows. ⁇ 1>.
- a capsule-like medication device A capsule-shaped casing, a board disposed inside the casing; a power receiving coil provided on the substrate; a secondary battery that can be charged with the power received by the power receiving coil; Equipped with The center of gravity of the capsule-shaped medication device is at a position different from the center of a cut plane when the capsule-shaped medication device is cut along a plane passing through the position of the center of gravity and orthogonal to the longitudinal direction of the capsule-shaped medication device.
- a capsule-shaped medication device characterized by being located at a position overlapping the substrate when viewed in a direction perpendicular to the substrate.
- the angle between a line connecting the center of gravity of the capsule-shaped medication device and the center of the cut surface and a reference line passing through the center of the cut surface and extending in a direction perpendicular to the substrate is 75° or less.
- the capsule-shaped medication device according to ⁇ 1> characterized in that: ⁇ 3>.
- ⁇ 4> According to any one of ⁇ 1> to ⁇ 3>, the center of gravity of the capsule-shaped medication device is located on a reference line that passes through the center of the cut surface and extends in a direction perpendicular to the substrate.
- capsule-shaped medication device ⁇ 5>. a biological information acquisition unit that acquires biological information; a signal transmitting unit that transmits the biological information acquired by the biological information acquiring unit; The capsule-shaped medication device according to any one of ⁇ 1> to ⁇ 4>, further comprising: ⁇ 6>.
- the housing is configured by combining a first divided housing and a second divided housing, The capsule-shaped medication device according to any one of ⁇ 1> to ⁇ 6>, wherein the weight of the first divided housing and the weight of the second divided housing are different. ⁇ 8>.
- a charging system for a capsule-shaped medication device comprising: ⁇ 9>.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Power Engineering (AREA)
- Medicinal Chemistry (AREA)
- Computer Networks & Wireless Communication (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Electromagnetism (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
カプセル状の筐体と、
前記筐体の内部に配置された基板と、
前記基板に設けられた受電コイルと、
前記受電コイルによって受電される電力を充電可能な二次電池と、
を備え、
前記カプセル状服薬デバイスの重心は、前記カプセル状服薬デバイスを、前記重心がある位置を通り、前記カプセル状服薬デバイスの長手方向と直交する平面で切断したときの切断面の中心とは異なる位置であって、かつ、前記基板と直交する方向に見たときに前記基板と重なる位置にあることを特徴とする。
複数の収容部と、複数の前記収容部の開口部を覆う金属製カバーとを有する収容シートと、
前記収容シートの前記収容部に収容される請求項1~7のいずれか一項に記載のカプセル状服薬デバイスと、
送電コイルを有し、前記収容部に前記カプセル状服薬デバイスが収容された前記収容シートが載置される充電器と、
を備えることを特徴とする。
<1>.カプセル状服薬デバイスであって、
カプセル状の筐体と、
前記筐体の内部に配置された基板と、
前記基板に設けられた受電コイルと、
前記受電コイルによって受電される電力を充電可能な二次電池と、
を備え、
前記カプセル状服薬デバイスの重心は、前記カプセル状服薬デバイスを、前記重心がある位置を通り、前記カプセル状服薬デバイスの長手方向と直交する平面で切断したときの切断面の中心とは異なる位置であって、かつ、前記基板と直交する方向に見たときに前記基板と重なる位置にあることを特徴とするカプセル状服薬デバイス。
<2>.前記カプセル状服薬デバイスの重心と前記切断面の中心とを結ぶ線と、前記切断面の中心を通り、前記基板と直交する方向に延伸する基準線との間の角度は、75°以下であることを特徴とする<1>に記載のカプセル状服薬デバイス。
<3>.前記カプセル状服薬デバイスの重心と前記切断面の中心とを結ぶ線と、前記基準線との間の角度は、45°以下であることを特徴とする<2>に記載のカプセル状服薬デバイス。
<4>.前記カプセル状服薬デバイスの重心は、前記切断面の中心を通り、前記基板と直交する方向に延伸する基準線上に位置することを特徴とする<1>~<3>のいずれか一つに記載のカプセル状服薬デバイス。
<5>.生体情報を取得する生体情報取得部と、
前記生体情報取得部によって取得された生体情報を送信する信号送信部と、
をさらに備えることを特徴とする<1>~<4>のいずれか一つに記載のカプセル状服薬デバイス。
<6>.前記信号送信部は、圧電素子であることを特徴とする<5>に記載のカプセル状服薬デバイス。
<7>.前記筐体は、第1の分割筐体と第2の分割筐体とを組み合わせて構成されており、
前記第1の分割筐体の重量と、前記第2の分割筐体の重量は異なることを特徴とする<1>~<6>のいずれか一つに記載のカプセル状服薬デバイス。
<8>.複数の収容部と、複数の前記収容部の開口部を覆う金属製カバーとを有する収容シートと、
前記収容シートの前記収容部に収容される<1>~<7>のいずれか一つに記載のカプセル状服薬デバイスと、
送電コイルを有し、前記収容部に前記カプセル状服薬デバイスが収容された前記収容シートが載置される充電器と、
を備えることを特徴とするカプセル状服薬デバイスの充電システム。
<9>.前記二次電池の充電を行うときに前記収容シートが前記充電器と接する部位は、前記金属製カバーとは反対側であることを特徴とする<8>に記載のカプセル状服薬デバイスの充電システム。
1a 第1の分割筐体
1b 第2の分割筐体
2 基板
3 受電コイル
4 二次電池
5 生体情報取得部
6 信号送信部
10 カプセル状服薬デバイス
11 カプセル状服薬デバイスの重心
12 カプセル状服薬デバイスを、重心がある位置を通り、長手方向と直交する平面で切断したときの切断面の中心
13 カプセル状服薬デバイスを、重心がある位置を通り、長手方向と直交する平面で切断したときの切断面
14 基準線
20 収容シート
21 収容部
22 金属製カバー
30 充電器
31 送電コイル
100 カプセル状服薬デバイスの充電システム
Claims (9)
- カプセル状服薬デバイスであって、
カプセル状の筐体と、
前記筐体の内部に配置された基板と、
前記基板に設けられた受電コイルと、
前記受電コイルによって受電される電力を充電可能な二次電池と、
を備え、
前記カプセル状服薬デバイスの重心は、前記カプセル状服薬デバイスを、前記重心がある位置を通り、前記カプセル状服薬デバイスの長手方向と直交する平面で切断したときの切断面の中心とは異なる位置であって、かつ、前記基板と直交する方向に見たときに前記基板と重なる位置にあることを特徴とするカプセル状服薬デバイス。 - 前記カプセル状服薬デバイスの重心と前記切断面の中心とを結ぶ線と、前記切断面の中心を通り、前記基板と直交する方向に延伸する基準線との間の角度は、75°以下であることを特徴とする請求項1に記載のカプセル状服薬デバイス。
- 前記カプセル状服薬デバイスの重心と前記切断面の中心とを結ぶ線と、前記基準線との間の角度は、45°以下であることを特徴とする請求項2に記載のカプセル状服薬デバイス。
- 前記カプセル状服薬デバイスの重心は、前記切断面の中心を通り、前記基板と直交する方向に延伸する基準線上に位置することを特徴とする請求項1~3のいずれか一項に記載のカプセル状服薬デバイス。
- 生体情報を取得する生体情報取得部と、
前記生体情報取得部によって取得された生体情報を送信する信号送信部と、
をさらに備えることを特徴とする請求項1~4のいずれか一項に記載のカプセル状服薬デバイス。 - 前記信号送信部は、圧電素子であることを特徴とする請求項5に記載のカプセル状服薬デバイス。
- 前記筐体は、第1の分割筐体と第2の分割筐体とを組み合わせて構成されており、
前記第1の分割筐体の重量と、前記第2の分割筐体の重量は異なることを特徴とする請求項1~6のいずれか一項に記載のカプセル状服薬デバイス。 - 複数の収容部と、複数の前記収容部の開口部を覆う金属製カバーとを有する収容シートと、
前記収容シートの前記収容部に収容される請求項1~7のいずれか一項に記載のカプセル状服薬デバイスと、
送電コイルを有し、前記収容部に前記カプセル状服薬デバイスが収容された前記収容シートが載置される充電器と、
を備えることを特徴とするカプセル状服薬デバイスの充電システム。 - 前記二次電池の充電を行うときに前記収容シートが前記充電器と接する部位は、前記金属製カバーとは反対側であることを特徴とする請求項8に記載のカプセル状服薬デバイスの充電システム。
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202380047453.7A CN119366086A (zh) | 2022-06-17 | 2023-03-14 | 胶囊状服药设备以及胶囊状服药设备的充电系统 |
| JP2024528301A JP7687531B2 (ja) | 2022-06-17 | 2023-03-14 | カプセル状服薬デバイスおよびカプセル状服薬デバイスの充電システム |
| US18/976,532 US20250099368A1 (en) | 2022-06-17 | 2024-12-11 | Capsule medication device and capsule medication device charging system |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022-097828 | 2022-06-17 | ||
| JP2022097828 | 2022-06-17 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US18/976,532 Continuation US20250099368A1 (en) | 2022-06-17 | 2024-12-11 | Capsule medication device and capsule medication device charging system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2023243164A1 true WO2023243164A1 (ja) | 2023-12-21 |
Family
ID=89192547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2023/009768 Ceased WO2023243164A1 (ja) | 2022-06-17 | 2023-03-14 | カプセル状服薬デバイスおよびカプセル状服薬デバイスの充電システム |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250099368A1 (ja) |
| JP (1) | JP7687531B2 (ja) |
| CN (1) | CN119366086A (ja) |
| WO (1) | WO2023243164A1 (ja) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025142041A1 (ja) * | 2023-12-28 | 2025-07-03 | 株式会社村田製作所 | 服用デバイス及び服用デバイスの情報取得システム |
| WO2025211400A1 (ja) * | 2024-04-02 | 2025-10-09 | 株式会社村田製作所 | 服用デバイス及び服用デバイスの情報取得システム |
| WO2026014299A1 (ja) * | 2024-07-08 | 2026-01-15 | 株式会社村田製作所 | 服用デバイス及びモジュール |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007330404A (ja) * | 2006-06-13 | 2007-12-27 | Olympus Corp | 無線給電システム及びこれを適用したカプセル内視鏡システム |
| JP2009125098A (ja) * | 2007-11-19 | 2009-06-11 | Olympus Corp | 無線給電システム |
| JP2010514461A (ja) * | 2006-12-28 | 2010-05-06 | オリンパスメディカルシステムズ株式会社 | カプセル型医療装置および体腔内観察方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005052637A (ja) * | 2003-07-18 | 2005-03-03 | Pentax Corp | カプセル型装置及びカプセル型装置駆動制御システム |
| CA2789262C (en) * | 2005-04-28 | 2016-10-04 | Proteus Digital Health, Inc. | Pharma-informatics system |
| CN102421350B (zh) * | 2009-03-11 | 2014-12-17 | 奥林巴斯医疗株式会社 | 图像处理系统、其外部装置及其图像处理方法 |
| JP5798407B2 (ja) * | 2011-08-09 | 2015-10-21 | Fdk株式会社 | 非接触充電対応型二次電池 |
| JP5807685B2 (ja) * | 2012-01-31 | 2015-11-10 | 富士通株式会社 | 受電装置及び電力供給システム |
| EP3060102B1 (en) * | 2013-10-22 | 2021-03-24 | Rock West Medical Devices, LLC | System to localize swallowable pill sensor with three transmitting elements |
| US9642525B2 (en) * | 2013-11-22 | 2017-05-09 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lens with retinal vascularization monitoring system |
| JP6890313B2 (ja) * | 2016-10-11 | 2021-06-18 | シグマ紙業株式会社 | Ptpシート用包装体及びその展開シート |
| WO2018081793A1 (en) * | 2016-10-31 | 2018-05-03 | Northeastern University | Reconfigurable implantable medical system for ultrasonic power control and telemetry |
| JP6712337B2 (ja) * | 2018-06-07 | 2020-06-17 | 光電子株式会社 | 受電装置、実験動物生体情報取得装置及び実験動物生体情報取得システム |
| JP7021722B2 (ja) * | 2019-10-01 | 2022-02-17 | 株式会社村田製作所 | 薬剤取出検知システム |
| WO2021090600A1 (ja) * | 2019-11-07 | 2021-05-14 | 株式会社村田製作所 | 服用検知システムおよび服薬デバイス |
| JP7436017B2 (ja) * | 2020-04-03 | 2024-02-21 | 株式会社タカゾノ | 判別装置 |
-
2023
- 2023-03-14 WO PCT/JP2023/009768 patent/WO2023243164A1/ja not_active Ceased
- 2023-03-14 CN CN202380047453.7A patent/CN119366086A/zh active Pending
- 2023-03-14 JP JP2024528301A patent/JP7687531B2/ja active Active
-
2024
- 2024-12-11 US US18/976,532 patent/US20250099368A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007330404A (ja) * | 2006-06-13 | 2007-12-27 | Olympus Corp | 無線給電システム及びこれを適用したカプセル内視鏡システム |
| JP2010514461A (ja) * | 2006-12-28 | 2010-05-06 | オリンパスメディカルシステムズ株式会社 | カプセル型医療装置および体腔内観察方法 |
| JP2009125098A (ja) * | 2007-11-19 | 2009-06-11 | Olympus Corp | 無線給電システム |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025142041A1 (ja) * | 2023-12-28 | 2025-07-03 | 株式会社村田製作所 | 服用デバイス及び服用デバイスの情報取得システム |
| WO2025211400A1 (ja) * | 2024-04-02 | 2025-10-09 | 株式会社村田製作所 | 服用デバイス及び服用デバイスの情報取得システム |
| WO2026014299A1 (ja) * | 2024-07-08 | 2026-01-15 | 株式会社村田製作所 | 服用デバイス及びモジュール |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7687531B2 (ja) | 2025-06-03 |
| CN119366086A (zh) | 2025-01-24 |
| JPWO2023243164A1 (ja) | 2023-12-21 |
| US20250099368A1 (en) | 2025-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7687531B2 (ja) | カプセル状服薬デバイスおよびカプセル状服薬デバイスの充電システム | |
| CN107924758B (zh) | 用于连接设备以使得能够在设备之间无线交换数据和/或功率的线缆单元 | |
| JP6975136B2 (ja) | データ及び電力のワイヤレス交換のためのバッテリモジュール | |
| US6931284B2 (en) | Implantable medical device with air core antenna assembly | |
| US9895053B2 (en) | Capsule type medical device | |
| CN103229383B (zh) | 可无线充电的电池和电力传输器 | |
| EP3160053B1 (en) | Antenna mandrel with multiple antennas | |
| JP6684897B2 (ja) | データ及び/又は電力のワイヤレス伝送のためのコネクタ及びデバイス | |
| CN104285358A (zh) | 非接触充电装置用天线板以及使用了该天线板的充电装置 | |
| US12263015B2 (en) | In-vivo implantable electronic device | |
| EP3804511B1 (en) | Power reception device, experimental animal biological information acquisition device, and experimental animal biological information acquisition system | |
| CN108140477A (zh) | 用于电力无线传输的可堆叠连接器和装置 | |
| JP6092926B2 (ja) | 電子機器 | |
| WO2026014301A1 (ja) | デバイス用基板、服用デバイス用モジュール、服用デバイス及び給電システム | |
| US12605089B2 (en) | Biological activity detection sensor | |
| US11730675B2 (en) | Medicine removal detection system | |
| WO2025057890A1 (ja) | 服用デバイス及び服用デバイスの情報取得システム | |
| WO2025057889A1 (ja) | 服用デバイス及び服用デバイスの情報取得システム | |
| JP2025059771A (ja) | 服用デバイス、服用デバイスの情報取得システム及び服用デバイスの製造方法 | |
| JP6226907B2 (ja) | コネクタ | |
| WO2025142041A1 (ja) | 服用デバイス及び服用デバイスの情報取得システム | |
| KR20250061374A (ko) | 박막형 자기유도코일 기반 무선 위치인식 모듈을 이용한 캡슐내시경, 이를 이용한 무선 위치인식 장치, 및 무선 위치인식 방법 | |
| WO2025211400A1 (ja) | 服用デバイス及び服用デバイスの情報取得システム | |
| WO2026014299A1 (ja) | 服用デバイス及びモジュール | |
| CN121311998A (zh) | 电池夹 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23823468 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2024528301 Country of ref document: JP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 202380047453.7 Country of ref document: CN |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWP | Wipo information: published in national office |
Ref document number: 202380047453.7 Country of ref document: CN |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 23823468 Country of ref document: EP Kind code of ref document: A1 |